News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Daily News HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds Michael O'Riordan August 13, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement Yael L. Maxwell August 06, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Daily News No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests Yael L. Maxwell May 21, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say Todd Neale March 17, 2020
News Daily News LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure Shelley Wood March 10, 2020
News Daily News Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk Caitlin E. Cox January 14, 2020